# Bioavailability of Clormadinone/Ethinyl Estradiol Tablets 2 mg/0.02 mg With Regards to Reference Product

> **NCT04713904** · PHASE1 · COMPLETED · sponsor: **Laboratorios Andromaco S.A.** · enrollment: 38 (actual)

## Conditions studied

- Bioequivalence

## Interventions

- **DRUG:** Clormadinone 2 mg and Ethinyl estradiol 0.02 mg Test Product Coated Tablets
- **DRUG:** Clormadinone 2 mg and Ethinyl estradiol 0.02 mg Reference Product Coated Tablets

## Key facts

- **NCT ID:** NCT04713904
- **Lead sponsor:** Laboratorios Andromaco S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-16
- **Primary completion:** 2021-01-16
- **Final completion:** 2021-02-02
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2021-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04713904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04713904, "Bioavailability of Clormadinone/Ethinyl Estradiol Tablets 2 mg/0.02 mg With Regards to Reference Product". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04713904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*